XML 17 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
Dec. 31, 2011
Dec. 31, 2010
Current Assets    
Cash $ 250,234 $ 23,516
Due from government agency 1,060 1,083
Prepaid expenses and deposits 56,627 700
Assets, Current, Total 307,921 25,299
Deferred financing costs (Note 5) 32,291 91,134
Assets, Total 340,212 116,433
Current Liabilities    
Accounts payable and accrued liabilities (Note 12) 794,291 809,292
Research agreement obligations (Note 3) 259,752 141,761
Convertible notes payable (Note 5) 998,790 353,050
Loans payable (Note 6) 7,000 425,000
Promissory note (Note 7) 100,000  
Due to related parties (Note 8) 322,905 259,305
Liabilities, Current 3,800,572 3,983,309
Capital stock (Note 9)    
Common stock, $0.001 par value, 150,000,000 shares authorized 52,073,460 shares issued and outstanding (2010 - 40,256,027) 52,072 40,256
Additional paid-in capital 39,943,374 37,812,058
Shares and warrants to be issued (Note 9) 362,906 34,980
Deferred compensation (Note 9) (35,968)  
Deficit accumulated during the development stage (43,722,216) (41,693,275)
Accumulated other comprehensive loss (60,528) (60,895)
Stockholders' Equity Attributable to Parent, Total (3,460,360) (3,866,876)
Liabilities and Equity, Total 340,212 116,433
COMMITMENTS AND CONTINGENCIES (Notes 1, 3, 5 and 12)      
Derivative liability - conversion option
    
Current Liabilities    
Derivative liability   175,389
Warrants
    
Current Liabilities    
Derivative liability $ 1,317,834 $ 1,819,512